U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Chronic furunculosis

MedGen UID:
869103
Concept ID:
C4023521
Disease or Syndrome
HPO: HP:0011132

Definition

A furuncle (boil) is a skin infection involving an entire hair follicle and nearby skin tissue. Chronic furunculosis refers to recurrent episodes of furuncles, often caused by recurrent staphylococcus infection. [from HPO]

Term Hierarchy

Conditions with this feature

Acne inversa, familial, 2
MedGen UID:
462387
Concept ID:
C3151037
Disease or Syndrome
Acne inversa is a chronic inflammatory disease of the hair follicles whose characteristic features include draining sinuses, painful skin abscesses, and disfiguring scars. Manifestations typically appear after puberty. Familial acne inversa is genetically heterogeneous (summary by Wang et al., 2010). Some patients with PSENEN-associated acne inversa also exhibit reticulate hyperpigmentation consistent with Dowling-Degos disease (DDD; see 179850) (Zhou et al., 2016). For a general phenotypic description and a discussion of genetic heterogeneity of acne inversa, see 142690.
Acne inversa, familial, 3
MedGen UID:
462388
Concept ID:
C3151038
Disease or Syndrome
Acne inversa, also known as hidradenitis suppurativa, is a chronic inflammatory disease of the hair follicles whose characteristic features include draining sinuses, painful skin abscesses, and disfiguring scars. Manifestations typically appear after puberty. Familial acne inversa is genetically heterogeneous (summary by Wang et al., 2010). For a general phenotypic description and a discussion of genetic heterogeneity of familial acne inversa, see 142690.
Immunodeficiency 51
MedGen UID:
934770
Concept ID:
C4310803
Disease or Syndrome
Immunodeficiency-51 (IMD51) is an autosomal recessive primary immune deficiency that is usually characterized by onset of chronic mucocutaneous candidiasis in the first years of life. Most patients also show recurrent Staphylococcal skin infections, and may show increased susceptibility to chronic bacterial respiratory infections. Patient cells show a lack of cellular responses to stimulation with certain IL17 isoforms, including IL17A (603149), IL17F (606496), IL17A/F, and IL17E (IL25; 605658) (summary by Levy et al., 2016).
Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection
MedGen UID:
1823965
Concept ID:
C5774192
Disease or Syndrome
Immunodeficiency-107 with susceptibility to invasive Staphylococcus aureus infection (IMD107) is an autosomal dominant immunologic disorder characterized most often by the development of invasive and severe life-threatening infections with S. aureus affecting the skin and/or lungs. There is incomplete penetrance (about 30%) and variable expressivity. In some patients with heterozygous OTULIN mutations, an infectious agent is not identified, suggesting that low-grade infectious or even noninfectious triggers may play a role in development of the disease. The levels and function of immune cells appear normal; the molecular defect resides in fibroblasts and possibly other nonhematopoietic barrier cells that show increased susceptibility to the detrimental effects of the S. aureus alpha-toxin (Spaan et al., 2022).

Professional guidelines

PubMed

Bernard P
Curr Opin Infect Dis 2008 Apr;21(2):122-8. doi: 10.1097/QCO.0b013e3282f44c63. PMID: 18317033
SHELMIRE DS, HARRELL ER
Postgrad Med 1965 Feb;37:202-6. doi: 10.1080/00325481.1965.11695439. PMID: 14255415
TULLOCH LG, ALDER VG, GILLESPIE WA
Br Med J 1960 Jul 30;2(5195):354-6. doi: 10.1136/bmj.2.5195.354. PMID: 13839797Free PMC Article

Recent clinical studies

Etiology

Bernard P
Curr Opin Infect Dis 2008 Apr;21(2):122-8. doi: 10.1097/QCO.0b013e3282f44c63. PMID: 18317033
Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, Etienne J
Br J Dermatol 2007 Dec;157(6):1161-7. Epub 2007 Oct 4 doi: 10.1111/j.1365-2133.2007.08197.x. PMID: 17916211
Aminzadeh A, Demircay Z, Ocak K, Soyletir G
J Dermatolog Treat 2007;18(2):105-8. doi: 10.1080/09546630601165125. PMID: 17520467

Diagnosis

Aminzadeh A, Demircay Z, Ocak K, Soyletir G
J Dermatolog Treat 2007;18(2):105-8. doi: 10.1080/09546630601165125. PMID: 17520467
Dada-Adegbola HO, Oluwatoba OA
West Afr J Med 2005 Oct-Dec;24(4):346-7. doi: 10.4314/wajm.v24i4.28231. PMID: 16483056

Therapy

Bernard P
Curr Opin Infect Dis 2008 Apr;21(2):122-8. doi: 10.1097/QCO.0b013e3282f44c63. PMID: 18317033
Aminzadeh A, Demircay Z, Ocak K, Soyletir G
J Dermatolog Treat 2007;18(2):105-8. doi: 10.1080/09546630601165125. PMID: 17520467
Wahba-Yahav AV
Acta Derm Venereol 1992 Nov;72(6):461-2. PMID: 1362845
Maibach HI, Strauss WG, Shinefield HR
Br J Dermatol 1969;81:Suppl 1:69+. doi: 10.1111/j.1365-2133.1969.tb12836.x. PMID: 5366167

Prognosis

Nowicka D, Grywalska E, Surdacka A, Grafka A, Roliński J
Microb Pathog 2019 Jan;126:85-91. Epub 2018 Oct 19 doi: 10.1016/j.micpath.2018.10.019. PMID: 30342909

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...